A Phase I Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients With Solid Tumor Malignancies.
Am J Clin Oncol
; 45(7): 294-297, 2022 07 01.
Article
in En
| MEDLINE
| ID: mdl-35700081
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Renal Cell
/
Kidney Neoplasms
/
Neoplasms
Limits:
Humans
Language:
En
Journal:
Am J Clin Oncol
Year:
2022
Document type:
Article
Affiliation country:
Macao
Country of publication:
Estados Unidos